Package 50268-260-13

Brand: divalproex sodium

Generic: divalproex sodium
NDC Package

Package Facts

Identity

Package NDC 50268-260-13
Digits Only 5026826013
Product NDC 50268-260
Description

30 BLISTER PACK in 1 BOX (50268-260-13) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-260-11)

Marketing

Marketing Status
Marketed Since 2022-09-16
Brand divalproex sodium
Generic divalproex sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "47e34870-0259-c99d-e063-6394a90ae59a", "openfda": {"unii": ["644VL95AO6"], "rxcui": ["1099563", "1099569"], "spl_set_id": ["e8cc336b-5191-7f8b-e053-2a95a90a6acb"], "manufacturer_name": ["AvPAK"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 BOX (50268-260-13)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (50268-260-11)", "package_ndc": "50268-260-13", "marketing_start_date": "20220916"}], "brand_name": "Divalproex Sodium", "product_id": "50268-260_47e34870-0259-c99d-e063-6394a90ae59a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Mood Stabilizer [EPC]"], "product_ndc": "50268-260", "generic_name": "Divalproex Sodium", "labeler_name": "AvPAK", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Divalproex Sodium", "active_ingredients": [{"name": "DIVALPROEX SODIUM", "strength": "500 mg/1"}], "application_number": "ANDA203730", "marketing_category": "ANDA", "marketing_start_date": "20220916", "listing_expiration_date": "20271231"}